New Analysis Method Melts DNA to Detect Pathogens Faster
This method is faster than blood cultures and is less likely to generate false positives compared to other DNA detection-based technologies.
This method is faster than blood cultures and is less likely to generate false positives compared to other DNA detection-based technologies.
Research from the Penn State College of Health and Human Development found that a new blood test for sepsis could save lives and money.
T2 Biosystems Inc. has submitted an application with the FDA for Breakthrough Device Designation for the company’s Candida auris test.
T2 Biosystems is expanding the number of pathogens detected on its T2Bacteria Panel to include the detection of Acinetobacter baumannii.
Read MoreA simple test that can be a beacon for improved patient outcomes, shorter lengths-of-stays, and reduced rates of antibiotic prescription and antibiotic resistance1-6
Read MoreCytovale revealed its 510(k) pending Cytovale system and 10-minute IntelliSep sepsis risk stratification test at AAACC.
Read MorePatients are 20% less likely to die of sepsis when detected by a new AI system that catches symptoms hours earlier than traditional methods.
Read MoreImproving outcomes with sepsis is dependent on timely diagnosis and treatment. Culture-independent testing is one way to save time.
Read MoreA new test can predict sepsis before blood clots cause organ damage by detecting shifts in blood protein abundance soon after infection.
Read MorePrenosis, Inc.is expanding its existing partnership with Roche Diagnostics that will to improve and expedite the clinical recognition of sepsis.
Read MoreResearchers have developed a new tool that could help provide early warnings of potentially deadly bacterial pathogens which cause sepsis, among other uses.
Read MoreKe Du, PhD, is developing a microfluidic device to improve detection of drug resistant bacteria in blood, one of the most common pathogens causing sepsis.
Read MoreIn screening for sepsis in newborns, there is a need to develop sensitive, and integrated diagnostic strategies to enhance detection.
Read MoreMagnolia Medical Technologies, Inc., announces its new Steripath Micro Initial Specimen Diversion Device designed for children’s hospitals.
Read MoreNanoDx, Inc., has entered into a licensing agreement with IBM Research for use of its nanoscale sensors for accurate, rapid testing.
Read MoreData from a new study published in JAMA Internal Medicine raises red flags surrounding the practice of relying on proprietary algorithms to warn of dangerous conditions, particularly one used to detect sepsis, reports Wired.
Read MoreFindings confirm that T2 Biosystems’ magnetic resonance technology for identification of bloodstream infections provides faster time to detection and shorter hospital stays.
Read MoreT2 Biosystems CEO John Sperzel has released a book about his personal experience with a bloodstream infection and sepsis, titled “Courage: Powerful Lessons in Leadership, Strength, and the Will to Succeed.”
Read More